Search

Your search keyword '"Joanna, Chorostowska-Wynimko"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Joanna, Chorostowska-Wynimko" Remove constraint Author: "Joanna, Chorostowska-Wynimko"
225 results on '"Joanna, Chorostowska-Wynimko"'

Search Results

1. Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium

2. Prevalence of Alpha-1 Antitrypsin Deficiency Alleles in a Lithuanian Cohort of Wheezing Small Children

3. Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review

5. Adult pneumococcal vaccination – new opportunities

6. Important steps towards a big change for lung health: a joint approach by the European Respiratory Society, the European Society of Radiology and their partners to facilitate implementation of the European Union's new recommendations on lung cancer screening

7. Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer

8. Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study

9. Alpha-1 Antitrypsin Z Variant (AAT PI*Z) as a Risk Factor for Intrahepatic Cholestasis of Pregnancy

10. Coalition Shaping the Vaccination Landscape

11. Research priorities in α1-antitrypsin deficiency: results of a patients' and healthcare providers' international survey from the EARCO Clinical Research Collaboration

12. Protocol for the EARCO Registry: a pan-European observational study in patients with α1-antitrypsin deficiency

14. Diagnosis and management of α1-antitrypsin deficiency in Europe: an expert survey

15. The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity Pneumonitis

17. The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions

18. Thoracic neoplasms

19. European Respiratory Society guideline on various aspects of quality in lung cancer care

22. Detection of EGFR mutations in liquid biopsy samples using allele-specific quantitative PCR: A comparative real-world evaluation of two popular diagnostic systems

23. BCG masking phenomena might depend on the species of Mycobacterium

24. Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death toll

25. FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer

26. Towards Better Pharmaceutical Provision in Europe-Who Decides the Future?

27. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers

28. Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study.

29. Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients

30. Enhanced expression of Fas Ligand (FasL) in the lower airways of patients with fibrotic interstitial lung diseases (ILDs)

31. Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency

34. Implementation of the User-Friendly Odds Ratio Calculator for Unvaccinated Individuals in a Country with a High COVID-19 Death Toll

35. Influence of Echinacea purpurea intake during pregnancy on fetal growth and tissue angiogenic activity.

36. Influence of Echinacea purpurea intake during pregnancy on fetal growth and tissue angiogenic activity.

37. SERPINA1 and More? A Putative Genetic Contributor to Pulmonary Dysfunction in Alpha-1 Antitrypsin Deficiency

38. Alpha-1 antitrypsin (AAT) augmentation therapy and liver phenotype in individuals with homozygous Pi*Z AAT mutation (Pi*ZZ genotype)

39. Morphometric and functional abnormalities of kidneys in the progeny of mice fed chocolate during pregnancy and lactation.

40. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

41. Einfluss der Augmentationstherapie mit Alpha1-Antitrypsin auf den Leberphänotyp von Individuen mit klassischem Alpha1-Antitrypsin-Mangel (Genotyp Pi*ZZ)

42. Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study

43. Late Breaking Abstract - Impact of COVID-19 on patients with severe alpha1 antitrypsin deficiency: the IMCA1 study of the EARCO ERS Clinical Research Collaboration, preliminary findings

44. The predictive value of circulating tumor DNA dynamics in plasma of EGFR-mutation-positive NSCLC patients on first line tyrosine kinase inhibitors

45. External quality assessment (EQA) for laboratory diagnosis of alpha1-antitrypsin deficiency (AATD) – Program driven by the European Alpha-1-Research Collaboration (EARCO) network

46. FGFR1 gene aberrations and FGFR1 protein expression in squamous non-small cell lung cancer (Sq-NSCLC)

47. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency

48. How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?

49. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients

Catalog

Books, media, physical & digital resources